Skip to main content

Table 5 Regression coefficients (β), R-squared values and p-values from linear regression analysis

From: Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study

Dependent variable

Independent variable

Placebo

Liraglutide

β

R2

p-value

β

R2

p-value

ΔAverage eʹ

Δheart rate

− 0.012

0.010

0.602

− 0.016

0.033

0.339

ΔAverage eʹ

Δweight

0.054

0.022

0.437

< 0.001

< 0.001

0.993

ΔAverage eʹ

ΔHbA1C

− 0.010

< 0.001

0.981

0.147

0.003

0.783

ΔAverage eʹ

ΔSystolic BP

0.006

0.010

0.603

0.002

0.001

0.882

ΔAverage eʹ

ΔDiastolic BP

− 0.010

0.008

0.639

− 0.023

0.081

0.127

Lateral eʹ velocity

Δheart rate

< 0.001

< 0.001

0.993

− 0.002

< 0.001

0.930

Lateral eʹ velocity

Δweight

0.008

< 0.001

0.944

− 0.040

0.012

0.572

Lateral eʹ velocity

ΔHbA1C

− 0.002

< 0.001

0.997

0.126

0.001

0.861

Lateral eʹ velocity

ΔSystolic BP

0.014

0.020

0.459

− 0.014

0.036

0.319

Lateral eʹ velocity

ΔDiastolic BP

− 0.016

0.009

0.628

− 0.026

0.061

0.189

Septal eʹ velocity

Δheart rate

− 0.029

0.044

0.277

− 0.023

0.070

0.167

Septal eʹ velocity

Δweight

0.111

0.074

0.154

0.021

0.006

0.685

Septal eʹ velocity

ΔHbA1C

0.084

0.001

0.857

0.452

0.028

0.388

Septal eʹ velocity

ΔSystolic BP

0.000

< 0.001

0.983

− 0.007

0.018

0.489

Septal eʹ velocity

ΔDiastolic BP

− 0.015

0.017

0.502

− 0.025

0.107

0.084

Average E/eʹ

Δheart rate

− 0.063

0.023

0.423

− 0.061

0.054

0.225

Average E/eʹ

Δweight

0.118

0.008

0.631

0.241

0.107

0.083

Average E/eʹ

ΔHbA1C

2.889

0.135

0.046

− 1.072

0.020

0.461

Average E/eʹ

ΔSystolic BP

− 0.008

0.002

0.836

− 0.010

0.004

0.735

Average E/eʹ

ΔDiastolic BP

− 0.045

0.014

0.539

0.055

0.064

0.185

  1. HbA1C glycated hemoglobin, BP blood pressure